ALPROLIX (Biogen Inc.)
Welcome to the PulseAid listing for the ALPROLIX drug offered from Biogen Inc.. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Biogen Inc. |
| NON-PROPRIETARY NAME: | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| SUBSTANCE NAME: | |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-05-05 |
| END MARKETING DATE: | 0000-00-00 |
ALPROLIX PLASMA DERIVATIVE Details:
| Item Description | ALPROLIX from Biogen Inc. |
| LABELER NAME: | Biogen Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2014-05-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64406-911_ec45b956-68f2-468e-9bdb-5c45d08aebf9 |
| PRODUCT NDC: | 64406-911 |
| APPLICATION NUMBER: | BLA125444 |